Clinical trial · Interventional
Integrated Short-Term Palliative Rehabilitation in Incurable Cancer
Integrated Short-term Palliative Rehabilitation to Improve Quality of Life and Equitable Care Access in Incurable Cancer: A Multi-national Randomised Controlled Trial
NCT05984797CI-TRIAL-00077389INSPIREunknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this intervention trial is to determine if palliative rehabilitation in addition to usual care is more effective than usual care at improving health-related quality of life in patients with incurable solid cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Integrated Short-term Palliative Rehabilitation | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- intervention arm
- description
- Integrated Short-term Palliative Rehabilitation + usual care
- interventionNames
- Other: Integrated Short-term Palliative Rehabilitation
- type
- NO_INTERVENTION
- label
- control arm
- description
- usual care
Primary outcomes (1)
- measure
- Health related quality of life
- timeFrame
- Assessed at 8 weeks after enrollment to the study
- description
- Assessed using Functional Assessment of Cancer Therapy (FACT-G) General scale, where high score indicates better functional well-being and quality of life for cancer patients. Lower scores may indicate a greater burden of symptoms, reduced ability to perform daily activities, and overall lower satisfaction with life during the cancer journey.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Aged 18 years or older. * Diagnosis of incurable solid cancer: lung, colorectal, breast, prostate or other, irrespective of timing in relation to any oncology or palliative care treatments * Eastern Cooperative Oncology Group performance status 2-3 * Able to provide informed consent and complete trial assessments in available languages. Exclusion Criteria: * Blood cancers: Leukaemia, Lymphoma, Myelodysplastic Syndromes (MDS), Myeloproliferative Disorder (MPD), Multiple Myeloma. * Currently receiving specialist rehabilitation\* for their cancer or co-morbidity-related dysfunction, or received within the two weeks prior to consent. * Clinician rated prognosis of less than 3 months.
References
Publications (0)
Data not yet available
No reference posted for this study.